Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lower Efficacy Rate Of J&J’s COVID-19 Vaccine Presents ‘Messaging Challenge’
Jan 30 2021
•
By
Brenda Sandburg
J&J's COVID-19 vaccine demonstrates 66% overall effectivess, 100% protection against hospitalization and death • Source: Shutterstock
More from Vaccines
More from Pink Sheet